Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Sinovac Starts Phase II Trial of Second Pandemic Flu Vaccine

publication date: Jun 30, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Sinovac Biotech will begin enrolling volunteers in a Phase II clinical trial of its split viron pandemic influenza vaccine. The whole viron version of the vaccine has already completed its Phase II tests. The split viron candidate is being examined because it has the potential for a lower side-effect profile, and the test is, as a result, being conducted among adolescents and children. Preliminary results from the test are expected in early 2009. More details...

Stock Symbol: (AMEX: SVA)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...